Max Heath

Essential Products, Smart Solutions

Max Health™ announces NZ registration of Neostigmine injection

Max Health™ is pleased to announce the advice received from Medsafe, that effective 19/03/2015, Neostigmine injection has been registered for use in New Zealand.  This product is manufactured in Europe and supplied to Max Health™ by Hameln Plus.

Medical Enquiries

If you have a medical enquiry regarding a Max Health product, please email or call us on 0800 678 001.

Reactions or Side Effects

To report an adverse event for a Max Health product please email or call us on 0800 678 001.

General Enquiries

For all other enquiries, please email or call us on 0800 678 001.

Head Office

Post

PO Box 444 52 Pt Chevalier Auckland 1246 New Zealand

Courier

Max Health 1F 29 Karaka St Eden Terrace Auckland 1010 New Zealand
2025 ©
barefoot web design